Replies to post #1187 on Idenix Pharmaceuticals (IDIX)

[Jonathan Robinson]

I sold my speculative long option position at minor gain after the open. I sold my long shares at break even for the day and close to break even overall. I lost a bunch of money keeping short puts out. Today's news removed one worry but added others - I personally still think the overall numbers in all arms were so high that it would have been very high to get much higher difference. I also think the 20% difference at the midpoint check and >10% change at week 4 will hopefully cause a re-gapping out when SVR data are known.

Jon

[DewDiligence]

>all considered today's news was positive for IDIX<

Prior to the CC—when it was revealed that phase-3 will be delayed by a year (or more)—I would have agreed with you for the simple reason that the data met the threshold to advance the program.

But the substantial delay makes the overall news at best neutral and probably modestly negative, IMO. Speed matters, and the NM283 program just lost whatever timing lead it had relative to VRTX and VPHM.